Kontrasepsiyonda Yenilikler - www.jinekolojivegebelik.com

KONTRASEPS İ YONDA YEN İ L İ KLER

Kontrasepsiyon Yöntemleri ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Kontrasepsiyon y ö ntemi etkinli ğ i ,[object Object],[object Object],[object Object],[object Object]

Failure Rates During the First Year of Use, United States 7 Percent of Women with PregnancyMethod Lowest Expected Typical No method 85.0% 85.0% Combination Pill 0.1 3.0 Progestin only 0.5 3.0 IUDs Progesterone IUD 1.5 2.0 Levonorgestrel IUD 0.6 0.8 Copper T 380A 0.1 0.1 Norplant 0.05 0.05 Female sterilization 0.05 0.05 Male sterilization 0.1 0.15 Depo-Provera 0.3 0.3 Spermicides 6.0 26.0

Failure Rates During the First Year of Use, United States 7 Percent of Women with PregnancyMethod Lowest Expected Typical Periodic abstinence 25.0 Calendar 9.0 Ovulation method 3.0 Symptothermal 2.0 Post-ovulation 1.0 Withdrawal 4.0 19.0 Cervical cap Parous women 26.0 40.0 Nulliparous women 9.0 20.0 Sponge Parous women 9.0 28.0 Nulliparous women 6.0 18.0 Diaphragm and spermicides 6.0 20.0 Condom Male 3.0 14.0 Female 5.0 21.0

Sterilizasyon ,[object Object],[object Object],[object Object],[object Object]

Laparas k opi k steriliza syon ,[object Object],[object Object],[object Object],[object Object],[object Object]

Female Tubal Sterilization Methods, 10-Year Cumulative Failure Rates 59 Unipolar coagulation 0.75% Postpartum tubal excision 0.75 Silastic (Falope or Yoon) ring 1.77 Interval tubal exclusion 2.01 Bipolar coagulation 2.48 Hulka-Clemens clip 3.65

Mini laparatomi ,[object Object],[object Object],[object Object]

Va z ektomi ,[object Object],[object Object],[object Object],[object Object]

S terilizasyon ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Oral kontraseptifler ,[object Object],[object Object],[object Object],[object Object],[object Object]

Progestinler ,[object Object],[object Object],[object Object],[object Object]

Oral kontraseptifler ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Ü lkemizdeki Oral Kontraseptifler ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Oral kontraseptifler ,[object Object],[object Object],[object Object],[object Object]

Oral konraseptifler ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Oral Kontraseptifler ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Oral Kontraseptifler ,[object Object],[object Object],[object Object],[object Object],[object Object]

Neoplastik etkiler ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Kontrasepsiyon D ışı Kullan ı mlar ı ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Oral Kontraseptiflerin Faydalar ı ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Oral kontraseptifler ve Ü reme ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Kesin Kontraendikasyonlar ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Tartışmalı Konular ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Oral Kontraseptif Kullan ımın da Takip ,[object Object],[object Object],[object Object],[object Object]

Yeni Form ü ller ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Yeni Progestinler ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Drospirenone ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Yeni Form ü ller ,[object Object],[object Object],[object Object]

30mcg EE+Drospirenone (Yasmin) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

30 mcg EE+Drospirenone/ 30mcgEE+Desogesterel ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Etki M ekanizmas ı ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Norplant , Etki Mekanizması ,[object Object],[object Object]

Kesin Kontraendikasyonlar ,[object Object],[object Object],[object Object],[object Object],[object Object]

Yan etkiler ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Depo provera ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Kontraendikasyonlar ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Olumlu Özellikleri ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Yeni enjektabl form ü ller 25mgMPA+5mg estradilcypionat ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Levonorgesterol RIA ,[object Object],[object Object],[object Object],[object Object],[object Object]

Levenorgesterol RIA ,[object Object],[object Object],[object Object],[object Object],[object Object]

Yan etkiler ,[object Object],[object Object],[object Object],[object Object]

Tek ç ubuk implantlar, Eto - norgesterel i ç eren EVA: I mplanon : ,[object Object],[object Object],[object Object],[object Object],[object Object]

Transdermal sistemler ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Vajinal halkalar ,[object Object],[object Object],[object Object],[object Object],[object Object]

Erkek hormonal kontrasepsiyon ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Erkek hormonal kontrasepsiyon ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Erkek hormonal kontrasepsiyon ,[object Object],[object Object],[object Object],[object Object]

Kontrasepsiyonda Yenilikler - www.jinekolojivegebelik.com

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (20)

Similaire à Kontrasepsiyonda Yenilikler - www.jinekolojivegebelik.com

Similaire à Kontrasepsiyonda Yenilikler - www.jinekolojivegebelik.com (20)

Plus de jinekolojivegebelik.com

Plus de jinekolojivegebelik.com (20)

Kontrasepsiyonda Yenilikler - www.jinekolojivegebelik.com